Saturday 17 October 2026 Export JAZZ’s income statement to Excel — free account

Jazz Pharmaceuticals PLC

Jazz Pharmaceuticals PLC’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, up 4.88% from fiscal 2024. In the quarter to June 2026, revenue grew 15.6%, EPS grew 126.0%, free cash flow grew 141.0% and total debt fell 18.9%, each against the same quarter a year earlier. Revenue growth for ten consecutive years.

210.05 4.37 −2.04%

Follow JAZZ

Alert me

Market cap: $13.9B
P/E: 13.8×
Fwd P/E: 17.3×
Dividend yield: —
F-score: 5/9
Altman Z: 1.37
Beneish M: −3.03
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	0.00	0.00	410.98	15.80
P/S ratio Full definition →		1.92	2.43	2.64	3.31
P/FCF ratio Full definition →		21.00	32.79	37.30	10.75
P/Operating CF Full definition →		16.85	28.60	28.67	36.64
P/B ratio Full definition →		2.02	2.40	2.58	3.17
Price to Tangible BV Full definition →		0.00	0.00	0.00	0.00
EV/Sales Full definition →		2.72	3.11	3.20	3.78
EV/EBITDA Full definition →		59.08	49.93	21.01	10.76
EV/Operating CF Full definition →		8.13	9.80	10.63	10.46
EV/FCF Full definition →		29.70	42.02	45.21	12.27
Quick Ratio Full definition →		1.24	1.46	1.65	1.38
Current Ratio Full definition →		1.65	1.86	2.04	1.78
Net Debt/EBITDA Full definition →		14.06	6.72	4.79	5.04
Debt/Assets Full definition →		47.21%	45.96%	45.15%	39.27%
Debt/Equity Full definition →		1.35	1.24	1.18	0.91
Asset Turnover Full definition →		0.35	0.36	0.38	0.42
Operating CF/Net income Full definition →		1.89	1.78	1.39	2.16
Capex/Depreciation Full definition →		(0.49)	(0.23)	(0.11)	(0.53)
Interest Coverage Full definition →		1.18	5.61	8.44	6.69
Research and Development Expense of Revenue Full definition →		17.60%	17.86%	18.34%	17.17%
Selling, General and Administrative Expense of Revenue Full definition →		47.12%	33.91%	33.00%	32.21%
Intangible Assets out of Total Assets Full definition →		0.56	0.54	0.51	0.53
Share Based Compensation of Revenue Full definition →		7.82%	5.91%	6.97%	6.07%
Graham Net Nets Full definition →		(0.46)	(0.31)	(0.23)	(0.15)
Graham Number Full definition →		0.00	0.00	27.53	161.46
Earnings Yield Full definition →		(4.52%)	(3.41%)	0.24%	6.33%
Free Cash Flow Yield Full definition →		4.76%	3.05%	2.68%	9.30%
Revenue per Share Full definition →		18.55	19.65	17.27	19.12
Operating CF per Share Full definition →		7.82	5.94	6.59	6.58
Capex per Share Full definition →		(1.44)	(0.69)	(0.32)	(1.50)
Free Cash Flow per Share Full definition →		6.38	5.26	6.28	5.07
Cash per Share Full definition →		33.71	40.04	46.43	34.81
Shareholders Equity per Share Full definition →		65.23	70.82	73.22	75.98
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		65.23	70.82	73.22	75.98
Free Cash Flow Full definition →		386.98	320.46	388.50	320.60
Working Capital Full definition →		1,481.78	1,923.50	2,336.50	1,737.40
Capital Expenditures Full definition →		(87.68)	(42.06)	(19.70)	(95.10)
Net Current Asset Value Full definition →		(3,641.58)	(3,174.70)	(2,744.20)	(2,311.00)
EV/EBIT Full definition →		0.00	0.00	0.00	19.38
Capex to Sales Full definition →		0.08	0.04	0.02	0.08
Price to Operating Income Full definition →		0.00	0.00	0.00	16.98
Other line items
Average Receivables Full definition →		744.00	773.73	744.65	797.45
Average Payables Full definition →		118.83	99.98	97.97	108.93
Average Inventory Full definition →		511.21	448.72	465.14	473.99
Average Assets Full definition →		11,806.11	11,835.78	11,697.14	11,012.52
Average Common Equity Full definition →		4,065.05	4,206.18	4,353.60	4,254.03

Fold the line items

Columns are period end dates

Stockrow Weekly